SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-035613
Filing Date
2021-03-12
Accepted
2021-03-12 16:40:03
Documents
1
Period of Report
2021-03-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218464-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm218464-3_4seq1.xml 4 3811
  Complete submission text file 0001104659-21-035613.txt   5182
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address
Wedell-Wedellsborg Johan (Reporting) CIK: 0001753185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 21738058